Important. These pages are retained here for historical purposes only and some of the information may be deprecated. The ICNA would like to thank everyone for making the congress a great success. We look forward to welcoming you again in Taipei, Taiwan for the ICNC2026.

Tuesday May 06 2014
Abstracts selected for presentation will be available online by April 15, 2014
08:00-09:00 PL03 The new technologies in neurorehabilitation Patrice L. Weiss, Israel
09:00-10:00 PL04 The impact of brain maturation on EEG development in childhood and some electroclinical syndromes (Frank Ford Lecture) Orvar Eeg-Olofsson, Sweden
10:30-12:30 S05 Genetics in Infantile Epileptic Encephalopathy 
CATARATAS I Chairs: Heung Dong Kim (South Korea) & Shinichi Hirose (Japan) 
      Genetics in infantile epileptic encephalopathy Heung Dong Kim , Korea, Repub.
Spectrum of PCDH19 Mutations Shinichi Hirose ,Japan
Dravet Syndrome: Update in 2013 Ingrid Scheffer ,Australia
Genetic mechanisms in dev. brain malformations in infantile epilepsy Hoon-Chul Kang , Korea, Repub.
Expanding genetic and molecular targets of epilepsy in infancy Yuwu Jiang ,China
10:30-12:30 S06 Leukoencephalopathies 
CATARATAS II Chair: Deborah Renaud (USA) 
    Clinical approach to leukodystrophies Sakkubai Naidu ,USA
Leukoencephalopathies associated with macrocephaly Deborah Renaud ,USA
Peroxisomal leukoencephalopathy Bwee-Tien Poll-The ,The Netherlands
10:30-12:30 S07 Cerebral Palsy 
IGUAÇU I Chairs: Pratibha Singhi (India) & Michael Johnston (USA) 
10:30 AM Treatment of Cerebral Palsy and its management in resource poor conditions Pratibha Singhi ,India
10:54 AM Activity-based therapies and neuroplasticity Diane Damiano, USA
11:18 AM Heterogeniety of CP Population Based Perspectives Michael Shevell ,Canada
11:42 AM Management of Cerebral Palsy from an International perspective Hans Forssberg ,Sweden
12:06 AM Neuroprotection to reduce incidence of CP Michael Johnston ,USA
10:30-12:30 S08 Childhood Headaches: Current Treatments and Research 
IGUAÇU II Chair: Kenneth Mack (USA) 
       Chronic Daily Headache Kenneth Mack ,USA
 Autonomic Instability and Migraine: "I am tired, dizzy and my head hurts all the time!" Eric M. Pearlman ,USA
 Chronic Daily Headache David Rothner ,USA
 Headache and school Marco Antônio Arruda ,Brazil
12:45-13:45 ICNA Council of delegates meeting (closed session) - IGUAÇU I
  Chair: TBA
0200 - 0215 PM FP51: Children with autsim and epilepsy:a descriptive clinical cohort study from south africa Nerica Ramsundhar, South Africa
0215 - 0230 PM FP52: Cognitive profile, neuropsychological disorders and concerns in patients with neurofibromatosis Type 1 Maria Puga, Argentina
0230 - 0245 PM FP53: Conners Continuous Performance Test profile in children with Attention Deficit Hyperactivity Disorder in relation to their intellectual performance Maria Puga, Argentina
0245 - 0300 PM FP54: Schooling of epileptic children. factors associated with the need for school support. Marina Aberastury, Argentina
0300 - 0315 PM FP55: FMR1 intron 1 methylation analysis: an epigenetic biomarker for the neurodevelopmental phenotype of children with Fragile X. Marta Arpone, Australia
0315 - 0330 PM FP56: The first European studies of lisdexamfetamine dimesylate in children with attention deficit/hyperactivity disorder Claudia Gasparian, Brazil
0330 - 0345 PM FP57: Pharmacokinetics and pharmacodynamics of the prodrug stimulant lisdexamfetamine dimesylate in children and adolescents with ADHD Claudia Gasparian, Brazil
0345 - 0400 PM FP58: Analysis of motor performance in infants with congenital hypothyroidism who began treatment in the first month of life Môyra Patresi, Brazil
0400- 0415 PM FP59: The importance of identifying neuropsychomotor delays in the development of young children Marcia Valiati, Brazil
0415 - 0430 PM FP60: Unexpected subclinical spikes: Clinical and Neurophysiological correlations Mark Mintz, USA
0430 - 0445 PM FP61: Modulation of the TMS-evoked N100 during a go/nogo task in children with ADHD Paolo Curatolo, Italy
0445- 0500 PM FP62: Correlation with urinary nonylphenol levels and clinical symptoms in children with attention-deficit hyperactivity disorder Jung-Chieh Du, Taiwan
14:00-17:00 CNS INFECTIONS
  Chair: TBA
0200 - 0215 PM FP65: Meningitis, Encephalitis, Myelitis and ADEM in Children: Automated Case Ascertainment (ChAT Analysis) in Real-Time Patrick Obermeier, Germany
0215 - 0230 PM FP64: Herpes-simplex encephalitis in patients with onco-hematological disease Mariana González Suarez, Argentina
0230 - 0245 PM FP63: Exogenous BDNF Improves Endogenous Neurogenesis Following Experimental Streptococcus Pneumoniae Meningitis Ling Li, China
0245 - 0300 PM FP66: Clinicoradiological outcomes in children with solitary neurocysticercosis with and without albendazole therapy: a retrospective case record analysis. Sheffali Gulati, India
0300 - 0315 PM FP67: CSF cultures / drug sensitivity in pediatric TBM - experience from a tertiary-care hospital in India Vrajesh Udani, India
0315 - 0330 PM FP68: Clinical Presentation and Prognosis of Pediatric Encephalitis : Experience of a Korean Single Tertiary Center Jun-Sung Park, China
0330 - 0345 PM FP69: Is that diagnostic lumbar puncture necessary? Venkateswaran Ramesh, UK
0345 - 0400 PM FP70: Shingles of the Brain-Recurrent Herpes Zoster Ophthalmicus causing  arteriopathy and BasalGanglia Infarction Jean-Pierre Lin, UK
0400- 0415 PM FP71: Paediatric Bacterial Meningitis in Southern Nigeria Angela Frank-Briggs, Nigeria
0415 - 0430 PM FP72: Opportunities of emergency chemoprophylaxis of tick-borne encephalitis in children Natalia Skripchenko, Russia
0430 - 0445 PM FP73: Paradoxical reaction in the central nervous system after tuberculosis treatment in an immunocompromised child Analia Pastrana, Argentina
0445- 0500 PM FP74: Etio-pathogenetic therapy of viral encephalitis in children Natalia Skripchenko, Russia
  Chair: TBA
0200 - 0215 PM FP75: Clinical outcomes in children younger than 12 years with multiple sclerosis treated with subcutaneous interferon beta-1a: subgroup analysis of a retrospective study (REPLAY) Silvia Tenembaum, Argentina
0215 - 0230 PM FP76: Diagnosing childhood small vessel CNS vasculitis: A proposed histological tool. Maryam Nabavi Nouri, Canada
0230 - 0245 PM FP77: Non-traumatic acute myelophaty: a series of 76 cases Hugo Arroyo, Argentina
0245 - 0300 PM FP78: Utility and Safety of Rituximab in pediatric autoimmune and inflammatory CNS disease Ming Lim, UK
0300 - 0315 PM FP79Clinical and Demographic Features of 389 Children with OMS: an International Cohort Elizabeth Tate, USA
0315 - 0330 PM FP80: Pharmacodynamics of immunotherapy for opsoclonus-myoclonus syndrome: impact on cytokines/chemokines Michael Pranzatelli, USA
0330 - 0345 PM FP81: Voltage Gated Potassium Channel (VGKC)-complex antibodies in children: what do they mean? Rahul Singh, UK
0345 - 0400 PM FP82: The Clinical Impact of Acute Demyelination of the Central Nervous System in Children Julia O'Mahony, Canada
0400- 0415 PM FP83: Spectrum of MOG autoantibody-associated demyelinating diseases in pediatric patients Silvia Tenembaum, Argentina
0415 - 0430 PM FP84: Myelin oligodendrocyte glycoprotein (MOG) antibodies in children without oligoclonal bands predict a non-MS course of acquired demyelination syndrome (ADS). Rahul Singh, UK
0430 - 0445 PM FP85: Therapeutic plasma exchange in paediatric neurology: indications, side effects and outcomes from four UK tertiary centres Cheryl Hemingway, UK
0445- 0500 PM FP86: Clinical characteristics of Irish narcolepsy patients following H1N1 influenza epidemic and vaccination in 2009/2010 Elaine Reade, Ireland
0500 - 0515 PM FP87: Autoimmune encephalitis in children: experience of a tertiary care teaching hospital in North India Rachna Dubey, India
  Chair: TBA
0200 - 0215 PM FP88: Perinatal stroke risk factors: Syndrome-controlled analysis in the Canadian Cerebral Palsy Registry Adam Kirton, Canada
0215 - 0230 PM FP89: Profile of Childhood Cerebrovascular Outpatient Clinic at Hospital in the South of Brazil Marcela Gonçalves, Brazil
0230 - 0245 PM FP90: Neurological involvement in children with E.Coli 0104:H4 induced Haemolytic Uraemic Syndrome Hans Hartmann, Germany
0245 - 0300 PM FP91: Is D-dimer measurement useful in pediatric cerebral sinovenous thrombosis? Mahendranath Moharir, Canada
0300 - 0315 PM FP92: Role of prothrombotic risk factors (thrombophilia) in neonatal arterial ischemic stroke Mahendranath Moharir, Canada
0315 - 0330 PM FP93: Robotic quantification of proprioceptive dysfunction in children with perinatal stroke Andrea Kuczynski, Canada
0330 - 0345 PM FP94: Hemicerebellitis: presentation of three cases Gabriela Reyes Valenzuela, Argentina
0345 - 0400 PM FP95: Malignant Middle Cerebral Artery Infarction in Children Andrea Andrade, Canada
0400- 0415 PM FP96: Posterior reversible encephalopathy syndrome: retrospective analysis of a pediatric intensive care unit Patricia Takahashi, Brazil
0415 - 0430 PM FP97: Isolated Bilateral Carotid Arteritis Presenting With Stroke In Childhood Kevin Shapiro, USA
0430 - 0445 PM FP98: Long-term Neuropsychological Outcome after Childhood Cerebral Sinovenous Thrombosis Mahendranath Moharir, Canada
0445- 0500 PM FP99: Hypothermia in hypoxic ischemic encephalopathy preliminary results in neurodevelopmental outcome Claudio Waisburg, Argentina